Log in
Enquire now
‌

US Patent 10799585 Stable aqueous formulations of adalimumab

Patent 10799585 was granted and assigned to Coherus BioSciences on October, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Coherus BioSciences
Coherus BioSciences
0
Current Assignee
Coherus BioSciences
Coherus BioSciences
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
107995850
Date of Patent
October 13, 2020
0
Patent Application Number
160231610
Date Filed
June 29, 2018
0
Patent Citations
‌
US Patent 10195275 Stable aqueous formulations of adalimumab
‌
US Patent 10155039 Stable aqueous formulations of adalimumab
‌
US Patent 10159732 Stable aqueous formulations of adalimumab
‌
US Patent 10159733 Stable aqueous formulations of adalimumab
‌
US Patent 10207000 Stable aqueous formulations of adalimumab
Patent Primary Examiner
‌
Yunsoo Kim
0
No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10799585 Stable aqueous formulations of adalimumab

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.